|
1
|
Ichigo S, Takagi H, Matsunami K, Murase T,
Ikeda T and Imai A: Transitional cell carcinoma of the ovary
(Review). Oncol Lett. 3:3–6. 2012.PubMed/NCBI
|
|
2
|
Lin CH, Liu FS and Ho ES: Transitional
cell carcinoma of the ovary. Taiwan J Obstet Gynecol. 45:268–271.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Robinson G: XX FIGO World Congress of
Gynecology and Obstetrics, Rome, Italy, 7–12 October 2012. J Fam
Plann Reprod Health Care. 39:502013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cannistra SA: Cancer of the ovary. N Engl
J Med. 351:2519–2529. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gadducci A, Cosio S, Zola P, Landoni F,
Maggino T and Sartori E: Surveillance procedures for patients
treated for epithelial ovarian cancer: A review of the literature.
Int J Gynecol Cancer. 17:21–31. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eichhorn JH and Young RH: Transitional
cell carcinoma of the ovary: A morphologic study of 100 cases with
emphasis on differential diagnosis. Am J Surg Pathol. 28:453–463.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ceauşu M, Terzea D, Georgescu A, Dobrea C,
Mihai M, Iosif C, Vasilescu F and Ardeleanu C: Transitional cell
tumors of the ovary: A compact group with a heterogeneous
histological and immunophenotypical pattern. Rom J Morphol Embryol.
49:513–516. 2008.PubMed/NCBI
|
|
8
|
Liao XY, Xue WC, Shen DH, Ngan HY, Siu MK
and Cheung AN: p63 expression in ovarian tumours: A marker for
Brenner tumours but not transitional cell carcinomas.
Histopathology. 51:477–483. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kommoss F, Kommoss S, Schmidt D, Trunk MJ,
Pfisterer J and du Bois A: Arbeitsgemeinschaft Gynaekologische
Onkologie Studiengruppe Ovarialkarzinom: Survival benefit for
patients with advanced-stage transitional cell carcinomas vs. other
subtypes of ovarian carcinoma after chemotherapy with platinum and
paclitaxel. Gynecol Oncol. 97:195–199. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tazi EM, Lalya I, Tazi MF, Ahellal Y,
M'rabti H and Errihani H: Transitional cell carcinoma of the ovary:
A rare case and review of literature. World J Surg Oncol. 8:982010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Silva EG, Robey-Cafferty SS, Smith TL and
Gershenson DM: Ovarian carcinomas with transitional cell carcinoma
pattern. Am J Clin Pathol. 93:457–465. 1990.PubMed/NCBI
|
|
12
|
Gershenson DM, Morris M, Burke TW,
Levenback C, Kavanagh JJ, Fromm GL, Silva EG, Warner D and Wharton
JT: Combined cisplatin and carboplatin chemotherapy for treatment
of advanced epithelial ovarian cancer. Gynecol Oncol. 58:349–355.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Musto A, Rampin L, Nanni C, Marzola MC,
Fanti S and Rubello D: Present and future of PET and PET/CT in
gynaecologic malignancies. Eur J Radiol. 78:12–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Antunovic L, Cimitan M, Borsatti E,
Baresic T, Sorio R, Giorda G, Steffan A, Balestreri L, Tatta R,
Pepe G, et al: Revisiting the clinical value of 18F-FDG PET/CT in
detection of recurrent epithelial ovarian carcinomas: Correlation
with histology, serum CA-125 assay, and conventional radiological
modalities. Clin Nucl Med. 37:e184–e188. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ebina Y, Watari H, Kaneuchi M, Takeda M,
Hosaka M, Kudo M, Yamada H and Sakuragi N: Impact of FDG PET in
optimizing patient selection for cytoreductive surgery in recurrent
ovarian cancer. Eur J Nucl Med Mol Imaging. 41:446–451. 2014.
View Article : Google Scholar : PubMed/NCBI
|
